Business registries · firm from USPTO records
ABRAXIS BIOSCIENCE, LLC
- Place
- 86 Morris Avenue, Summit, NJ
- Entity type
- Limited liability company
- State of organization
- DE (as the owner states it in trademark filings)
- Patents
- 22 granted 1993-06-24 to 2025-06-10
- Trademarks
- 11, 9 live
- Record
- EXACT high confidence: identical full name and state
- State business registration
- ABRAXIS BIOSCIENCE LLC EXACT high confidence: identical full name and state
- Source
- USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12324860 | Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin | 2025-06-10 | PVGPATDIS, file of 2026-04-10 |
| US 12133844 | Methods of treating epithelioid cell tumors | 2024-11-05 | PVGPATDIS, file of 2026-04-10 |
| US 12061183 | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug | 2024-08-13 | PVGPATDIS, file of 2026-04-10 |
| US 11944708 | Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin | 2024-04-02 | PVGPATDIS, file of 2026-04-10 |
| US 11497737 | Pharmaceutical compositions of albumin and rapamycin | 2022-11-15 | PVGPATDIS, file of 2026-04-10 |
| US 11320416 | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug | 2022-05-03 | PVGPATDIS, file of 2026-04-10 |
| US 10973806 | Methods of treating epithelioid cell tumors comprising administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin | 2021-04-13 | PVGPATDIS, file of 2026-04-10 |
| US 10900951 | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel | 2021-01-26 | PVGPATDIS, file of 2026-04-10 |
| US 10744110 | Methods of treating lung cancer | 2020-08-18 | PVGPATDIS, file of 2026-04-10 |
| US 10705070 | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug | 2020-07-07 | PVGPATDIS, file of 2026-04-10 |
| US 10682420 | Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane | 2020-06-16 | PVGPATDIS, file of 2026-04-10 |
| US 10660965 | Methods of enhancing drug delivery and effectiveness of therapeutic agents | 2020-05-26 | PVGPATDIS, file of 2026-04-10 |
| US 10555912 | Use of polymeric excipients for lyophilization or freezing of particles | 2020-02-11 | PVGPATDIS, file of 2026-04-10 |
| US 10527604 | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel | 2020-01-07 | PVGPATDIS, file of 2026-04-10 |
| US 10413531 | Methods of treating bladder cancer | 2019-09-17 | PVGPATDIS, file of 2026-04-10 |
| US 10328031 | Methods of treating pancreatic cancer | 2019-06-25 | PVGPATDIS, file of 2026-04-10 |
| US 10258565 | Intravascular delivery of nanoparticle compositions and uses thereof | 2019-04-16 | PVGPATDIS, file of 2026-04-10 |
| US 10206887 | Prion free nanoparticle compositions and methods of making thereof | 2019-02-19 | PVGPATDIS, file of 2026-04-10 |
| US 10076501 | Use of polymeric excipients for lyophilization or freezing of particles | 2018-09-18 | PVGPATDIS, file of 2026-04-10 |
| US 10053504 | SPARC binding ScFvs | 2018-08-21 | PVGPATDIS, file of 2026-04-10 |
| US 9962373 | Methods of treating bladder cancer | 2018-05-08 | PVGPATDIS, file of 2026-04-10 |
| US 9884013 | Intravascular delivery of nanoparticle compositions and uses thereof | 2018-02-06 | PVGPATDIS, file of 2026-04-10 |
| US 9855220 | Methods of treating pancreatic cancer | 2018-01-02 | PVGPATDIS, file of 2026-04-10 |
| US 9820949 | Methods of treatment of pancreatic cancer | 2017-11-21 | PVGPATDIS, file of 2026-04-10 |
| US 9724323 | Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane | 2017-08-08 | PVGPATDIS, file of 2026-04-10 |
Trademarks
| Mark | Serial | Filed | Status | Classes | Source |
|---|---|---|---|---|---|
| SPARC MICROENVIRONMENT SIGNATURE (SMS) | 86043850 | 2013-08-21 | Registration cancelled | 044 | TRCFECO2, file of 2024-03-27 |
| POWER OF THE NANO-DIMENSION | 77154250 | 2007-04-11 | Registration cancelled | 005 | TRCFECO2, file of 2024-03-27 |
| A ABRAXIS BIOSCIENCE | 78865006 | 2006-04-19 | Registered and renewed | 005, 042, 044 | TRCFECO2, file of 2024-03-27 |
| ABRAXIS | 78857197 | 2006-04-08 | Registered and renewed | 044 | TRTDXFAP, file of 2025-12-07 |
| ABRAXIS BIOSCIENCE | 78800790 | 2006-01-27 | Registered and renewed | 005, 042, 044 | TRCFECO2, file of 2024-03-27 |
| ARC OF SUPPORT | 78549399 | 2005-01-18 | Registered and renewed | 044 | TRTDXFAP, file of 2025-05-11 |
| ABRAXANE | 78415969 | 2004-05-10 | Registered and renewed | 005 | TRTDXFAP, file of 2026-04-30 |
| ABRAXIS | 78334600 | 2003-12-01 | Registration cancelled | 005, 042 | TRTDXFAP, file of 2026-10-20 |
| NAB | 78290740 | 2003-08-21 | Registered and renewed | 005 | TRCFECO2, file of 2024-03-27 |
| ABRAXANE | 78282011 | 2003-08-01 | Registered and renewed | 005 | TRTYRAP, file of 2026-04-03 |
| EMLA | 74406470 | 1993-06-24 | Registration cancelled | 005 | TRTDXFAP, file of 2026-04-30 |
Possible related entities
- Avila Therapeutics, Inc. firm from USPTO records, 2 trademarks FUZZY same street address (trademark filings)
- Celgene Corporatin firm from USPTO records, 1 trademarks FUZZY same street address (trademark filings)
- Celgene Corporation firm from USPTO records, 402 patents, 630 trademarks FUZZY same street address (trademark filings)
- Celgene Corporatoin firm from USPTO records, 2 trademarks FUZZY same street address (trademark filings)
- CNA Holdings Inc. firm from USPTO records, 4 trademarks FUZZY same street address (trademark filings)
- Impact Biomedicines, Inc. firm from USPTO records, 2 patents, 6 trademarks FUZZY same street address (trademark filings)
- Juno Therapeutics, Inc. firm from USPTO records, 3 trademarks FUZZY same street address (trademark filings)
Sharing an address can mean a parent and subsidiary, a shared office or a registered agent; it isn’t proof of a connection.
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.